Alkixen 250 mg is a tradition drug of Crizotinib, an anaplastic carcinoma kinase( ALK) and ROS1 tyrosine kinase asset( TKI) specified solely for the treatment of a specific type ofnon-small cell lung cancer( NSCLC). Manufactured under strict pharmaceutical norms, Alkixen is primarily approved for cases whose excrescences are ALK-positive( anaplastic carcinoma kinase-positive) or ROS1-positive, as determined by an FDA- approved test.

Crizotinib, the active component of Alkixen 250 mg, blocks the exertion of abnormal ALK and ROS1 proteins that lead to cancer cell proliferation. By blocking similar kinases, Alkixen slows or halts cancer development, leading to apoptosis( cell death) and reducing excrescence size in the maturity of cases.

Alkixen 250 mg is indicated for

Adult cases with metastatic NSCLC that's ALK-positive.

Cases with ROS1-positive metastatic NSCLC.

Before initiating treatment, confirm ALK or ROS1 gene rearrangements using molecular individual tests.

The cure of Alkixen should be 250 mg orally doubly daily. It should be swallowed whole with water and may be administered with or without food. Lozenge adaptation should be made in the case of bloodied liver function, medicine relations, or dogmatism.

Important Safety Information

Contraindications

Acuity to Crizotinib or expression constituents.

Hepatotoxicity Monitoring of liver function on a regular base.

QT Interval extension Abnormal heart meter can be caused; ECG monitoring may be possible.

Bradycardia Monitoring of heart rate; cure adaptation may be demanded.

Interstitial Lung complaint/ Pneumonitis Treatment should be stopped if there are signs.

Visual Disturbances Frequent; generally mild but to be reported.

Medicine relations

Alkixen is metabolized by the enzyme CYP3A4. Strong corrupters or impediments of the enzyme CYP3A4 can alter its tube attention.

Avoid attendant use with medicines known to protract QT interval.

Common side goods are

Disturbances of vision( double vision, blurred vision)

Nausea and puking

Diarrhoea or constipation

Fatigue

Swelling

Elevated liver function tests

Storage Conditions

Keep Alkixen tablets in a cool dry place below 30 °C. Out of reach of children. Do n't use after expiry date on pack.

Not to be used during gestation or lactation unless easily indicated.

Proper contraception to be used.

Proper contraception to be used during remedy and for a while after conclusion.

Regular close monitoring by imaging, laboratory examination, and physical examinations should be performed to assess the efficacity and safety of treatment.

Alkixen 250 mg( Crizotinib) is a important advance in targeted oncology for cases with ALK- or ROS1-positive metastatic NSCLC. By targeting the unique cancer motorists at their inheritable origin, Alkixen delivers bettered issues with an respectable side effect profile. Always consult an oncologist or healthcare provider before starting or modifying any cancer treatment authority.